These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7625703)

  • 1. Recombinant toxins: new therapeutic agents for cancer.
    Pastan IH; Pai LH; Brinkmann U; Fitzgerald DJ
    Ann N Y Acad Sci; 1995 Jun; 758():345-54. PubMed ID: 7625703
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant immunotoxins: new therapeutic agents for cancer treatment.
    Pastan IH
    Cancer Detect Prev; 1993; 17(2):289-93. PubMed ID: 8402714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxin therapy for cancer.
    Pai LH; Pastan I
    JAMA; 1993 Jan; 269(1):78-81. PubMed ID: 8416411
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudomonas exotoxin: recombinant conjugates as therapeutic agents.
    FitzGerald DJ; Pastan I
    Biochem Soc Trans; 1992 Nov; 20(4):731-4. PubMed ID: 1487051
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted therapy of cancer with recombinant immunotoxins.
    Pastan I
    Biochim Biophys Acta; 1997 Oct; 1333(2):C1-6. PubMed ID: 9395287
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant immunotoxins.
    Pastan I; Pai LH; Brinkmann U; FitzGerald D
    Breast Cancer Res Treat; 1996; 38(1):3-9. PubMed ID: 8825117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First immunotoxin therapy for many common solid tumors enters phase I clinical trial.
    Skolnick AA
    JAMA; 1993 Nov; 270(19):2280. PubMed ID: 8230582
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotoxins and recombinant toxins for cancer treatment.
    Pai LH; Pastan I
    Important Adv Oncol; 1994; ():3-19. PubMed ID: 8206493
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetically engineered proteins for immunoregulation.
    Strom TB; Steele AW; Nichols J
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):18-20. PubMed ID: 7482811
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotoxins and recombinant toxins in the treatment of solid carcinomas.
    Theuer CP; Pastan I
    Am J Surg; 1993 Sep; 166(3):284-8. PubMed ID: 8368439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant toxins.
    Kreitman RJ; Pastan I
    Adv Pharmacol; 1994; 28():193-219. PubMed ID: 8080817
    [No Abstract]   [Full Text] [Related]  

  • 12. Midwest symposium seeks therapeutic answers to global AIDS problem.
    Goldsmith MF
    JAMA; 1990 Jan; 263(3):345-6. PubMed ID: 2104639
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice.
    Reiter Y; Wright AF; Tonge DW; Pastan I
    Int J Cancer; 1996 Jul; 67(1):113-23. PubMed ID: 8690511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotechnological and gene therapeutic strategies in cancer treatment.
    Wels W; Moritz D; Schmidt M; Jeschke M; Hynes NE; Groner B
    Gene; 1995 Jun; 159(1):73-80. PubMed ID: 7607575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New AIDS drugs take careful aim.
    Palca J
    Science; 1989 Dec; 246(4937):1559-60. PubMed ID: 2595368
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotoxins in the treatment of refractory hairy cell leukemia.
    Kreitman RJ; Pastan I
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1137-51, viii. PubMed ID: 16990113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of targeted toxins.
    Frankel AE; Tagge EP; Willingham MC
    Semin Cancer Biol; 1995 Oct; 6(5):307-17. PubMed ID: 8562908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant single-chain immunotoxins against T and B cell leukemias.
    Kreitman RJ; Pastan I
    Leuk Lymphoma; 1994 Mar; 13(1-2):1-10. PubMed ID: 8025511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Pseudomonas exotoxin to hematologic malignancies.
    Kreitman RJ; Pastan I
    Semin Cancer Biol; 1995 Oct; 6(5):297-306. PubMed ID: 8562907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of a recombinant immunotoxin in a tumor in vivo: fewer than 1000 molecules per cell are sufficient for complete responses.
    Kreitman RJ; Pastan I
    Cancer Res; 1998 Mar; 58(5):968-75. PubMed ID: 9500458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.